Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleClinical Investigation

Neurologic Symptoms After 177Lu-Prostate-Specific-Membrane Antigen-617 Therapy: A Single-Center Experience

Gokce Belge Bilgin, Brian J. Burkett, Cem Bilgin, Jacob J. Orme, Daniel S. Childs, Miguel Muniz Rincon, Ahmad S. Abdelrazek, Derek R. Johnson, Geoffrey B. Johnson, Eugene D. Kwon, Oliver Sartor and Ayse Tuba Kendi
Journal of Nuclear Medicine September 2024, 65 (9) 1402-1408; DOI: https://doi.org/10.2967/jnumed.124.267643
Gokce Belge Bilgin
1Department of Radiology, Mayo Clinic, Rochester, Minnesota;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Brian J. Burkett
1Department of Radiology, Mayo Clinic, Rochester, Minnesota;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cem Bilgin
1Department of Radiology, Mayo Clinic, Rochester, Minnesota;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jacob J. Orme
2Department of Oncology, Mayo Clinic, Rochester, Minnesota;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daniel S. Childs
2Department of Oncology, Mayo Clinic, Rochester, Minnesota;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Miguel Muniz Rincon
2Department of Oncology, Mayo Clinic, Rochester, Minnesota;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ahmad S. Abdelrazek
1Department of Radiology, Mayo Clinic, Rochester, Minnesota;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Derek R. Johnson
1Department of Radiology, Mayo Clinic, Rochester, Minnesota;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Geoffrey B. Johnson
1Department of Radiology, Mayo Clinic, Rochester, Minnesota;
3Department of Immunology, Mayo Clinic, Rochester, Minnesota; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eugene D. Kwon
3Department of Immunology, Mayo Clinic, Rochester, Minnesota; and
4Department of Urology, Mayo Clinic, Rochester, Minnesota
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Oliver Sartor
1Department of Radiology, Mayo Clinic, Rochester, Minnesota;
2Department of Oncology, Mayo Clinic, Rochester, Minnesota;
4Department of Urology, Mayo Clinic, Rochester, Minnesota
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ayse Tuba Kendi
1Department of Radiology, Mayo Clinic, Rochester, Minnesota;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 65 no. 9 1402-1408
DOI 
https://doi.org/10.2967/jnumed.124.267643
PubMed 
39089816

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Received for publication February 19, 2024
  • Accepted for publication July 10, 2024
  • Published online September 3, 2024.

Article Versions

  • previous version (August 1, 2024 - 10:25).
  • You are viewing the most recent version of this article.
Copyright & Usage 
© 2024 by the Society of Nuclear Medicine and Molecular Imaging.

Author Information

  1. Gokce Belge Bilgin1,
  2. Brian J. Burkett1,
  3. Cem Bilgin1,
  4. Jacob J. Orme2,
  5. Daniel S. Childs2,
  6. Miguel Muniz Rincon2,
  7. Ahmad S. Abdelrazek1,
  8. Derek R. Johnson1,
  9. Geoffrey B. Johnson1,3,
  10. Eugene D. Kwon3,4,
  11. Oliver Sartor1,2,4 and
  12. Ayse Tuba Kendi1
  1. 1Department of Radiology, Mayo Clinic, Rochester, Minnesota;
  2. 2Department of Oncology, Mayo Clinic, Rochester, Minnesota;
  3. 3Department of Immunology, Mayo Clinic, Rochester, Minnesota; and
  4. 4Department of Urology, Mayo Clinic, Rochester, Minnesota
  1. For correspondence or reprints, contact Gokce Belge Bilgin (belgebilgin.gokce{at}mayo.edu).
View Full Text

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: August 2024 to April 2025

AbstractFullPdf
Aug 2024197613980
Sep 202413355141
Oct 20244342720
Nov 20243491310
Dec 2024310148
Jan 2025250189
Feb 2025167186
Mar 2025367840
Apr 20253215494
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 65 (9)
Journal of Nuclear Medicine
Vol. 65, Issue 9
September 1, 2024
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Complete Issue (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Neurologic Symptoms After 177Lu-Prostate-Specific-Membrane Antigen-617 Therapy: A Single-Center Experience
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Neurologic Symptoms After 177Lu-Prostate-Specific-Membrane Antigen-617 Therapy: A Single-Center Experience
Gokce Belge Bilgin, Brian J. Burkett, Cem Bilgin, Jacob J. Orme, Daniel S. Childs, Miguel Muniz Rincon, Ahmad S. Abdelrazek, Derek R. Johnson, Geoffrey B. Johnson, Eugene D. Kwon, Oliver Sartor, Ayse Tuba Kendi
Journal of Nuclear Medicine Sep 2024, 65 (9) 1402-1408; DOI: 10.2967/jnumed.124.267643

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Neurologic Symptoms After 177Lu-Prostate-Specific-Membrane Antigen-617 Therapy: A Single-Center Experience
Gokce Belge Bilgin, Brian J. Burkett, Cem Bilgin, Jacob J. Orme, Daniel S. Childs, Miguel Muniz Rincon, Ahmad S. Abdelrazek, Derek R. Johnson, Geoffrey B. Johnson, Eugene D. Kwon, Oliver Sartor, Ayse Tuba Kendi
Journal of Nuclear Medicine Sep 2024, 65 (9) 1402-1408; DOI: 10.2967/jnumed.124.267643
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Visual Abstract
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • DISCLOSURE
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • 177Lu-PSMA-617 Consolidation Therapy After Docetaxel in Patients with Synchronous High-Volume Metastatic Hormone-Sensitive Prostate Cancer: A Randomized, Phase 2 Trial
  • Transarterial Radioembolization in the TACOME Trial: Dosimetric Analysis and Clinical Features in Predicting Response and Overall Survival
  • Retreatment of Metastatic Castration-Resistant Prostate Cancer Patients with 223Ra Therapy in Daily Practice
Show more Clinical Investigation

Similar Articles

Keywords

  • prostate cancer
  • theranostics
  • radionuclide therapy
  • 177Lu-PSMA-617
  • neurologic findings
SNMMI

© 2025 SNMMI

Powered by HighWire